Human defensin-1 (HNP-1) is a peptide possessing both broad antimicrobial (both Gram-positive and Gram-negative bacteria) and cytotoxic activities. HNP-1 reduces adenoviral infection by more than 95%.
CAT No: 10-101-279
CAS No:99287-08-8
Synonyms/Alias:Defensin HNP-1 human >=80% (HPLC);99287-08-8;136661-76-2(free acid basis);Defensin HNP-3 (human) trifluoroacetate salt;FD110457;FD110458;Defensin HNP-1 (human) trifluoroacetate salt;
Defensin HNP-1 (Human) is a cationic antimicrobial peptide belonging to the human neutrophil peptide (HNP) family, which plays a crucial role in innate immunity. Structurally characterized by its triple-disulfide stabilized β-sheet motif, HNP-1 is predominantly found in azurophilic granules of neutrophils and is released during immune responses to microbial invasion. Its broad-spectrum antimicrobial activity and immunomodulatory properties have made it a prominent subject of research in host defense mechanisms, inflammation, and innate immune signaling. As a synthetic or recombinant peptide, HNP-1 serves as a valuable biochemical tool for elucidating peptide-mediated biological processes and for developing novel research applications in immunology and microbiology.
Antimicrobial mechanism studies: HNP-1 is widely employed in investigations of antimicrobial peptide action, particularly in dissecting the molecular basis of membrane disruption in bacteria, fungi, and enveloped viruses. Its ability to interact with microbial membranes, leading to pore formation and cell lysis, provides a model for understanding innate immune defense strategies. Researchers utilize HNP-1 to probe the physicochemical determinants of peptide-membrane interactions, assess resistance mechanisms in pathogens, and screen for novel antimicrobial agents inspired by its structure and function.
Immunomodulation research: The peptide is instrumental in studies exploring the regulatory effects of defensins on immune cell signaling, cytokine production, and chemotaxis. By modulating the activity of monocytes, dendritic cells, and T lymphocytes, HNP-1 enables researchers to analyze the cross-talk between innate and adaptive immunity. Its use in in vitro and ex vivo assays supports the identification of pathways involved in inflammation, immune cell recruitment, and the resolution of infectious or inflammatory insults.
Cell signaling and receptor interaction assays: HNP-1 serves as a probe for examining the interaction of antimicrobial peptides with cell surface receptors, such as toll-like receptors (TLRs) and chemokine receptors. These studies elucidate how defensins influence intracellular signaling cascades, gene expression, and cellular responses beyond direct antimicrobial action. Insights gained from such applications contribute to a deeper understanding of peptide-mediated modulation of host defense and tissue homeostasis.
Peptide structure-function analysis: The robust and well-characterized structure of HNP-1 makes it an ideal template for structure-activity relationship (SAR) studies. Researchers synthesize analogs and mutants to map the contributions of specific amino acid residues and disulfide bonds to antimicrobial potency, stability, and immunomodulatory activity. These investigations advance the rational design of peptide therapeutics and biomimetic molecules for research and development in antimicrobial and immunological fields.
Biochemical assay development: HNP-1 is frequently incorporated as a positive control or reference standard in a variety of biochemical and microbiological assays. Its reproducible antimicrobial and immunomodulatory effects support the validation of assay sensitivity, specificity, and reproducibility. Laboratories engaged in screening novel antimicrobial compounds or evaluating immune-modulating agents benefit from the inclusion of HNP-1 in their experimental workflows, ensuring robust and interpretable results.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More